Studio GYDIAR

Studio GYDIAR brings a multi-disciplinary product development capability specifically oriented around medical devices and laboratory biotools designed for multi-market regulatory compliance. Key strengths include:

Cross-market regulatory design expertise: Deep knowledge of NMPA, CE/MDR (EU), and FDA regulatory pathways, enabling device architectures to be engineered for simultaneous multi-market submissions from the first design iteration.

OEM platform adaptation methodology: Proven capability to take existing OEM hardware — including diagnostic instruments, sample handling systems, and laboratory devices — and re-engineer both the industrial design and technical documentation for Western market regulatory approval.

Rapid prototyping and design validation: Structured methodology for taking a concept from functional specification through industrial design, engineering, and validated prototype within compressed timelines using local Shanghai-based manufacturing resources.

Biotool and medtech convergence: Specific expertise in laboratory biotools at the intersection of diagnostics and medical devices — including detection instruments, assay platforms, sample processing hardware, and point-of-care systems — bridging the gap between research tools and regulated medical devices.

Investment-ready design packages: Ability to deliver regulatory strategy documents, design history files, and investor-grade technical dossiers that accelerate both regulatory submissions and funding rounds simultaneously.